1 |
dipeptidyl peptidase-4
(1894 times)
|
Endocrinology (431 times)
|
GLP-1 (549 times) T2DM (296 times) SGLT2 (123 times)
|
2004 Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes.
|
2 |
dipeptidyl peptidase-4 inhibitor
(25 times)
|
Endocrinology (7 times)
|
GLP-1 (8 times) T2DM (5 times) T1D (4 times)
|
2011 Linagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus.
|
3 |
dipeptidase-4
(5 times)
|
Biology (2 times)
|
ACE-2 (1 time) BALF (1 time) CI (1 time)
|
2015 Diabetes therapies in hemodialysis patients: Dipeptidase-4 inhibitors.
|
4 |
Dipeptidyl peptidase type 4
(4 times)
|
Endocrinology (2 times)
|
GLP-1 (3 times) GLP-1R (1 time) HFF (1 time)
|
2017 Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathy.
|
5 |
dipeptidyl-4
(2 times)
|
Medicine (1 time)
|
---
|
2014 Factors associated with utilization of dipeptidyl-4 inhibitors in patients with type 2 diabetes mellitus: a cross-sectional retrospective study.
|
6 |
dietary proteins possess dipeptidyl peptidase-4
(1 time)
|
Nutritional Sciences (1 time)
|
GLP-1 (1 time)
|
2020 Glucagon-like peptide-1 response to whey protein is less diminished by dipeptidyl peptidase-4 in comparison with responses to dextrin, a lipid and casein in rats.
|
7 |
Dipeptidyl peptidase 4/CD26
(1 time)
|
Endocrine System Diseases (1 time)
|
BMD (1 time) BMI (1 time)
|
2015 High Levels of Serum DPP-4 Activity Are Associated with Low Bone Mineral Density in Obese Postmenopausal Women.
|
8 |
dipeptidyl transferase-4
(1 time)
|
Chemistry, Pharmaceutical (1 time)
|
ACE2 (1 time) AMPK (1 time) COVID (1 time)
|
2021 Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease.
|
9 |
DPP-4-siRNA
(1 time)
|
Chemistry (1 time)
|
HCAECs (1 time) siRNA (1 time) VEGF (1 time)
|
2017 Combination of exendin-4 and DPP-4 silencing promoted angiogenesis of human coronary artery endothelial cells via activation of PI3K/Akt pathway.
|